Skystar Bio-Pharmaceutical Co.    SEC # 1076939

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  1/15/99   —   First EDGAR Filing:  11/16/99   –   Last Filing:  4/9/19  (None in the Past Year) 

Business Address      On:  4/9/19       [ Map ]		Mailing Address      On:  4/9/19       [ Map ]
Rm 10601, Jiezuo Plaza, No. 4 Fenghui Road South, Gaoxin District Xian Province China

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 407-645-4433		Nevada, U.S.A.		12/31/yy		33-0901534		0001076939		001-34394

Industry Classification
SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2834 Pharmaceutical Preparations 2019 SEC Office of Life Sciences 7372 Prepackaged Software 2007 SEC Office of Technology 7819 Services Allied to Motion Picture Production 2004 SEC Office of Trade & Services

        

Management
Director   In   Lu Weibing 2005-2014   Wen Wei 2005-2012   CA   Fan Qiang 2008-2012   Chen Mark D 2009-2012   Cramer Russell Scott 2012   Shen Weirong 2012 ↓List Pre-2010 Directors				Officer  Since  Most-Recent Title   In   VA   Mei Bing 2011 Chief Financial Officer 2014   Lu Weibing 2005 Chief Executive Officer 2014   Wen Wei 2005 Vice President, Secretary 2012   CA   Lan Michael Hongjie Chief Financial Officer 2010 ↓List Pre-2010 Officers

        

        

        

        

Securities
CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2016:   830884 830884·10·2     re: ‘13F-HR/A’ – 7/31/08 830884·20·1     re: ‘13F-HR/A’ – 11/17/09 830884·30·0     Common Par $.001 _________  Classes source:  Form 13F Filings that list Section 13(f) Securities